946524-37-4 Usage
Description
2-Oleoyl Glycerol-d5 is a deuterated form of 2-Oleoylglycerol, a metabolite of 2-acylglycerol. It is commonly used as a biomarker in various applications.
Uses
Used in Biomarker Applications:
2-Oleoyl Glycerol-d5 is used as a biomarker for monitoring metabolic processes and assessing the presence of specific compounds in biological samples.
Used in Research and Development:
2-Oleoyl Glycerol-d5 is used as a research tool in the development of new drugs and therapies, as well as in the study of metabolic pathways and disease mechanisms.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Oleoyl Glycerol-d5 is used as a reference compound for the development and validation of analytical methods and assays.
Used in Clinical Diagnostics:
2-Oleoyl Glycerol-d5 is used as a diagnostic marker in clinical settings to aid in the identification and monitoring of various diseases and conditions.
Used in Food Industry:
In the food industry, 2-Oleoyl Glycerol-d5 can be used as a tracer compound to study the metabolism of fats and oils, as well as to develop new food products with improved nutritional profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 946524-37-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,6,5,2 and 4 respectively; the second part has 2 digits, 3 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 946524-37:
(8*9)+(7*4)+(6*6)+(5*5)+(4*2)+(3*4)+(2*3)+(1*7)=194
194 % 10 = 4
So 946524-37-4 is a valid CAS Registry Number.
946524-37-4Relevant articles and documents
Quantitative method for the profiling of the endocannabinoid metabolome by LC-atmospheric pressure chemical ionization-MS
Williams, John,Wood, JodiAnne,Pandarinathan, Lakshmipathi,Karanian, David A.,Bahr, Ben A.,Vouros, Paul,Makriyannis, Alexandros
, p. 5582 - 5593 (2008/03/12)
The endocannabinoid system's biological significance continues to grow as novel endocannabinoid metabolites are discovered. Accordingly, a myopic view of the system that focuses solely on one or two endocannabinoids, such as anandamide or 2-arachidonoyl glycerol, is insufficient to describe the biological responses to perturbations of the system. Rather, the endocannabinoid metabolome as a whole must be analyzed. The work described here is based on liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry. This method has been validated to quantify, in a single chromatographic run, the levels of 15 known or suspected metabolites of the endocannabinoid system in the rat brain and is applicable to other biological matrixes. We have obtained an endocannabinoid profile specifically for the frontal cortex of the rat brain and have determined anandamide level differences following the administration of the fatty acid amide hydrolase inhibitor AM374.
